Two seminal studies from 缅北强奸, investigating immune landscapes of lung and brain tumours, were published today in Nature. This work was led by Logan Walsh, Daniela Quail and Peter Siegel, researchers at the Rosalind and Morris Goodman Cancer Institute and Philippe Joubert from Universit茅 Laval. The studies used innovative highly multiplexed imaging to create sophisticated immune atlases of lung and brain tumours and demonstrate how big data and artificial intelligence are the future of cancer research and clinical care.
Published on: 2 Feb 2023
Thinning in the right temporo-parietal cortex and left prefrontal cortex were similar in both groups
A new study led by scientists at The Neuro (Montreal Neurological Institute-Hospital) of 缅北强奸 finds a correlation between neurodegeneration in obese people and Alzheimer鈥檚 disease (AD) patients.
Category:
Published on: 31 Jan 2023
Consortium brings together hundreds of researchers from 28 networks, 11 trial units across the country
Today the Canadian Institutes of Health Research (CIHR) announced funding for a new clinical trial consortium co-chaired by Dr. Guy Rouleau, Director of The Neuro (Montreal Neurological Hospital-Institute).听听
Category:
Published on: 19 Jan 2023
Discovery will improve diagnosis and open treatment possibilities for thousands of people with this debilitating neurodegenerative condition worldwide
A new study published on Dec. 14, 2022 in the New England Journal of Medicine reports the identification of a previously unknown genetic cause of a late-onset cerebellar ataxia, a discovery that will improve diagnosis and open new treatment avenues for this progressive condition.
Category:
Published on: 15 Dec 2022
Software tool brings together multiple brain maps in one place
The brain is a complex organ, and no one imaging mode can catch everything that鈥檚 going on inside it. Over the years, multiple 鈥渂rain maps鈥� have emerged, each focusing on different brain processes, from metabolism to cognitive function. While these maps are important, using them in isolation limits the discoveries researchers can make from them.
Category:
Published on: 6 Oct 2022
Purpose is to understand post-COVID symptom evolution and impact on patients鈥� lives
As of Sept. 20, 2022, there have been more than 1.1 million cases of COVID-19 in Quebec. It is estimated that 10 to 30 per cent of cases will have lingering symptoms after the acute illness. This means that as many as 330,000 Quebecers may experience what鈥檚 become known as long COVID, or post-COVID-19 syndrome.
Category:
Published on: 20 Sep 2022
Society recognizes distinguished Canadians who have made remarkable contributions to their academic fields and public life
Two faculty members at The Neuro (Montreal Neurological Institute-Hospital) have been inducted into The Royal Society of Canada (RSC), recognizing their contributions to our understanding of neuroscience and the human brain.
Category:
Published on: 6 Sep 2022
The Neuro joins two other 缅北强奸-affiliated organizations in signing The Declaration on Research Assessment
The Neuro (Montreal Neurological Institute-Hospital) has joined the Douglas Research Centre (DRC) and the Canadian Open Neuroscience Platform (CONP) in signing the San Francisco Declaration on Research Assessment (DORA), an agreement that seeks to change how scholarly research contributions are valued in hiring, promotion, and funding decisions.
Category:
Published on: 10 Aug 2022
Together with Dr. Birgit Frauscher, Bernhardt co-directs The Neuro鈥檚 new Centre of Excellence in Epilepsy
Since joining The Neuro in 2016, Boris Bernhardt, PhD, Assistant Professor of Neurology and Neurosurgery, has published pioneering research on the organization and development of the healthy brain. His achievements have been recognized this week by the Canadian Association for Neuroscience, who have awarded him the 2022 New Investigator Award.
Category:
Published on: 12 Apr 2022
Applying machine learning to a database of testimonials uncovers how drug-induced changes in subjective awareness are mechanistically rooted in the human brain
Psychedelics are now a rapidly growing area of neuroscience and clinical research, one that may produce much-needed new therapies for disorders such as depression and schizophrenia. Yet there is still a lot to know about how these drug agents alter states of consciousness.
Category:
Published on: 16 Mar 2022
YCharOS is an independent quality assessment initiative to improve research results听
An antibody characterization project with partners at The Neuro will be able to expand thanks to funding from G茅nome Qu茅bec.听听
Category:
Published on: 14 Mar 2022
Machine learning algorithms enhanced technical performance and learning outcomes during simulated brain tumor removal
The COVID-19 pandemic has presented both challenges and opportunities for medical training. Remote learning technology has become increasingly important in several fields. A new study finds that in a remote environment, an artificial intelligence (AI) tutoring system can outperform expert human instructors.
Category:
Published on: 22 Feb 2022
The Neuro and the CERVO Brain Research Centre join forces to pave the way for much needed biomarker discovery in brain diseases
Category:
Published on: 13 Dec 2021
Seven CIHR funded projects at 缅北强奸 and the Research Institute of the 缅北强奸 Health Centre to investigate impacts of vaccine hesitancy, health-care shortages, work-life imbalance for children, youth, and families in the context of the COVID-19 pandemic.
Published on: 10 Dec 2021
The 鈥�5-SENSE鈥� score can predict who will not benefit from stereo-electroencephalography
A new study from The Neuro (Montreal Neurological Institute-Hospital) and eight collaborating international epilepsy centers has developed a simple web-based application clinicians can use to predict which patients will not benefit from an invasive diagnostic work-up, preventing unnecessary, invasive procedures, saving time for patients and the clinical team, and freeing up overburdened health resources.
Category:
Published on: 6 Dec 2021
Pages
